15 Einträge gefunden

1. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues.

   1. van Bömmel, Florian
   2. Man, de
   3. Robert, A
   4. Wedemeyer, Heiner
   5. Deterding, Katja
   6. Buggisch, Peter
   7. Buggisch, Peter

   2010 - Forschungsinformationssystem des UKE
2. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients.

   1. Berg, Thomas
   2. Weich, Viola
   3. Teuber, Gerlinde
   4. Klinker, Hartwig
   5. Möller, Bernd
   6. Rasenack, Jens
   7. Hinrichsen, Holger

   2009 - Forschungsinformationssystem des UKE
3. Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection.

   1. Schulze Zur Wiesch, Julian
   2. Pieper, Dorothea
   3. Stahmer, Ingrid
   4. Eiermann, Thomas
   5. Buggisch, Peter
   6. Lohse, Ansgar W.
   7. Hauber, Joachim

   2009 - Forschungsinformationssystem des UKE
4. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.

   1. Deterding, K
   2. Wiegand, J
   3. Grüner, N
   4. Hahn, A
   5. Jäckel, E
   6. Jung, M C
   7. Buggisch, Peter

   2009 - Forschungsinformationssystem des UKE
5. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.

   1. Halangk, Juliane
   2. Sarrazin, Christoph
   3. Neumann, Konrad
   4. Puhl, Gero
   5. Mueller, Tobias
   6. Teuber, Gerlinde
   7. Klinker, Hartwig

   2008 - Forschungsinformationssystem des UKE
6. Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

   1. von Wagner, Michael
   2. Hofmann, Wolf Peter
   3. Teuber, Gerlinde
   4. Berg, Thomas
   5. Goeser, Tobias
   6. Spengler, Ulrich
   7. Hinrichsen, Holger

   2008 - Forschungsinformationssystem des UKE
7. Mycophenolate mofetil as second line therapy in autoimmune hepatitis?

   1. Hennes, Elke
   2. Oo, Ye H
   3. Schramm, Christoph
   4. Denzer, Ulrike W.
   5. Buggisch, Peter
   6. Wiegard, Christiane
   7. Kanzler, Stephan

   2008 - Forschungsinformationssystem des UKE
8. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.

   1. Rodríguez-Torres, Maribel
   2. Govindarajan, Sugantha
   3. Solá, Ricard
   4. Clumeck, Nathan
   5. Lissen, Eduardo
   6. Pessôa, Mário
   7. Buggisch, Peter

   2008 - Forschungsinformationssystem des UKE
9. Treatment of chronic hepatitis C with consensus interferon in relapsers and non-responders to interferon-based therapy.

   1. Steffen, M
   2. Cornberg, M
   3. Buggisch, Peter

   2007 - Forschungsinformationssystem des UKE
10. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial.

    1. Kronenberger, Bernd
    2. Berg, Thomas
    3. Herrmann, Eva
    4. Hinrichsen, Holger
    5. Gerlach, Tilman
    6. Buggisch, Peter
    7. Spengler, Ulrich

    2007 - Forschungsinformationssystem des UKE
11. Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.

    1. Wiegand, Johannes
    2. Cornberg, Markus
    3. Aslan, Nuray
    4. Schlaphoff, Verena
    5. Sarrazin, Christoph
    6. Kubitschke, Anne
    7. Buggisch, Peter

    2007 - Forschungsinformationssystem des UKE
12. Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.

    1. Wursthorn, Karsten
    2. Lütgehetmann, Marc
    3. Dandri-Petersen, Maura
    4. Volz, Tassilo
    5. Buggisch, Peter
    6. Zollner, Bernhard
    7. Longerich, Thomas

    2006 - Forschungsinformationssystem des UKE
13. Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.

    1. Wursthorn, Karsten
    2. Buggisch, Peter
    3. Lütgehetmann, Marc
    4. Zollner, Bernhard
    5. Petersen, Jorg

    2006 - Forschungsinformationssystem des UKE
14. Bioavailability of oral iron drugs as judged by a 59Fe-whole-body counting technique in patients with iron deficiency anaemia. Therapeutic efficacy of iron(II)-glycine sulfate.

    1. Nielsen, Peter
    2. Kongi, Rosemarie
    3. Buggisch, Peter
    4. Fischer, Roland

    2005 - Forschungsinformationssystem des UKE
15. Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases.

    1. Nielsen, Peter
    2. Fischer, Roland
    3. Buggisch, Peter
    4. Janka-Schaub, Gritta

    2003 - Forschungsinformationssystem des UKE